查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539331

聚己内酯市场：2024-2032年全球产业分析、规模、占有率、成长、趋势、预测

Polycaprolactone Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 300 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份有关全球聚己内酯市场的详细报告。本报告对关键市场动态进行了全面分析，包括驱动因素、趋势、机会和挑战，提供了对市场结构的深入见解。

关键见解

  • 聚己内酯市场规模（2024年）：6.697亿美元
  • 市场预测金额（2032年）：13.652亿美元
  • 全球市场成长率（2024-2032年年复合成长率）：8.2%

聚己内酯市场：研究范围

聚己内酯市场涵盖多种应用和产品，特别是在生物分解塑胶、树脂和医疗设备的生产中。聚己内酯（PCL）是一种低熔点、生物分解的聚酯，广泛用作热塑性聚氨酯、生物医学材料和药物传输系统的成分。市场涵盖生物医学领域、包装产业、特种化学品等多个领域。成长的推动因素包括日益成长的环境问题导致对生物分解材料的需求、医疗技术的进步以及 PCL 在各种工业过程中的广泛使用。

推动市场成长的因素：

推动全球聚己内酯市场有几个关键因素。在环境法规和消费者意识的推动下，对生物分解塑胶的需求不断成长，显着推动市场发展。聚己内酯与其他聚合物混合的多功能性扩大了其在包装和医疗行业的用途。此外，组织工程、药物传输和缝合线等生物医学应用的扩大也推动了市场的扩张。这种材料易于加工且与各种製造技术相容，使其成为製造客製化设计的生物医学设备的最爱，支持市场的稳定成长。

市场限制因素：

儘管成长前景广阔，但聚己内酯市场面临着与 PCL 生产相关的高成本和更便宜的替代品的可用性等挑战。与传统聚合物相比，聚己内酯的製造过程可能很昂贵，这可能会限制其在成本敏感市场的采用。此外，聚乳酸（PLA）和聚羟基脂肪酸酯（PHA）等替代生物降解材料的存在也可能具有竞争力，因为它们通常可以以较低的成本获得。另一个好处是，某些地区对 PCL 益处的认识较低，这可能会阻碍市场成长。

市场机会：

聚己内酯日益用于药物输送系统和3D列印等高价值应用，市场存在巨大机会。对个人化医疗和患者特定植入物的需求不断成长，为基于 PCL 的产品提供了机会，可以根据个人需求提供可自订的特性。目的是增强机械性能和生物降解性的新型 PCL 复合材料和共混物的开发预计将满足生物医学和包装行业日益成长的需求。此外，不断发展的循环经济和永续发展举措为广泛采用聚己内酯作为传统塑胶的环保替代品提供了肥沃的土壤。

本报告解决的关键问题

  • 推动全球聚己内酯市场成长的关键因素是什么？
  • 不同产业中使用的聚己内酯有哪些种类和应用？
  • 技术进步如何影响聚己内酯市场的竞争格局？
  • 谁是聚己内酯市场的主要参与者？
  • 全球聚己内酯市场的新趋势和未来前景如何？

目录

第1章 执行摘要

第2章 市场介绍

  • 市场分类
  • 市场定义

第3章 市场前景

  • 母市场前景
  • 价值链分析
  • 生命週期分析
  • 聚己内酯的能源需求
  • 主要法规
  • 宏观经济因素
  • 预测因子：相关性和影响

第4章 市场动态

  • 市场驱动因素
  • 市场限制
  • 市场趋势
  • 市场机会

第5章 COVID-19 对市场的影响

  • 新冠肺炎（COVID-19）的现状
  • 各国国家封锁的影响
  • COVID-19 危机的经济影响情景
  • 全球受冠状病毒爆发影响的产业
  • 受灾最严重产业的復苏预测
  • 冠状病毒对工作世界的影响
  • 新冠肺炎（COVID-19）对製造业的影响
  • 2024年製造业采购经理指数
  • 新冠肺炎（COVID-19）对全球供应链的影响
  • COVID-19 大流行期间的规划与管理
  • 企业领导者应关注的未来指南

第6章 COVID-19 对聚己内酯市场的影响

  • COVID-19 对聚己内酯市场的影响和价值：依国家/地区划分，2020年
  • 聚己内酯销售预测：2020年 COVID-19 大流行期间
  • COVID-19 之前的市场预测与 COVID-19 之后的市场预测

第7章 全球聚己内酯市场分析

  • 简介
    • 市场金额预测
    • 市场规模（MT）预测
    • 市场规模及年成长率
    • 绝对数量的机会
  • 世界价格分析
  • 强度映射

第8章 全球聚己内酯市场分析：依形式

  • 简介
  • 2019-2023年历史市场规模（百万美元）和数量（公尺）分析：依形式
  • 2024-2032年当前市场规模（百万美元）和数量（公尺）分析和预测：依形式
    • 颗粒
    • 奈米球
    • 微球
  • 市场吸引力分析：依格式

第9章 全球聚己内酯市场分析：依生产方法

  • 简介
  • 2019-2023年历史市场规模（百万美元）和产量（公尺）分析：依生产方法
  • 2024-2032年当前市场规模（百万美元）和产量（公尺）的分析和预测：依生产方法
    • 开环聚合
    • 羧酸的缩聚
  • 地方吸引力分析：依生产方法

第10章 全球聚己内酯市场分析：依应用

  • 简介
  • 2019-2023年历史市场规模（百万美元）和数量（公尺）分析：依应用
  • 2024-2032年当前市场规模（百万美元）和数量（公尺）分析和预测：依应用
    • 热塑性聚氨酯
    • 医疗保健
    • 其他
  • 市场吸引力分析：依平台

第11章 全球聚己内酯市场分析：依地区

  • 2019-2023年依地区历史市场规模（百万美元）及数量（公尺）分析
  • 2024-2032年依地区划分的当前市场规模（百万美元）和数量（公尺）分析和预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东南亚和太平洋地区（SEAP）
    • 中东和非洲（MEA）
    • 日本
    • 中国
  • 市场吸引力分析：依地区划分

第12章 北美聚己内酯市场分析

第13章 拉丁美洲聚己内酯市场分析

第14章 欧洲聚己内酯市场分析

第15章 东南亚和太平洋地区（SEAP）聚己内酯市场分析

第16章 中国聚己内酯市场分析

  • 简介
  • 2019-2023年依细分市场划分的历史市场规模（百万美元）和数量（公尺）分析
  • 2024-2032年依细分市场划分的市场规模（百万美元）和数量（公尺）预测
    • 依形式
    • 依生产方式
    • 依用途
  • 市场吸引力分析

第17章 日本聚己内酯市场分析

第18章 中东与非洲（MEA）聚己内酯市场分析

第19章 竞争状况（製造业）

  • 市占率分析
  • 竞争状况
  • 市占率分析
  • 竞争仪表板
  • 公司简介
    • Perstorp Holding A. B.
    • BASF SE
    • Diacel Corporation
    • Sigma-Aldrich Corporation（Merck）
    • Durect Corporation
    • Corbion Purac
    • Shenzen Esun Industrial Co. Ltd.
    • Haihang Industries Co., Ltd.
    • Polysciences, Inc.
    • Shenzhen Polymtek Biomaterial Co. Ltd.

第20章 研究方法

第21章 使用的先决条件与缩写

简介目录
Product Code: PMRREP4522

Persistence Market Research has recently published an extensive report on the global Polycaprolactone Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Polycaprolactone Market Size (2024E): USD 669.7 Mn
  • Projected Market Value (2032F): USD 1,365.2 Mn
  • Global Market Growth Rate (CAGR 2024 to 2032): 8.2%

Polycaprolactone Market - Report Scope:

The Polycaprolactone Market encompasses a variety of applications and products, particularly in the manufacturing of biodegradable plastics, resins, and medical devices. Polycaprolactone (PCL) is a biodegradable polyester with a low melting point, widely used in the production of thermoplastic polyurethanes, biomedical materials, and as a component in drug delivery systems. The market caters to diverse segments, including the biomedical sector, packaging industry, and specialty chemicals. Growth is driven by increasing environmental concerns leading to the demand for biodegradable materials, advancements in medical technology, and the expanding application of PCL in various industrial processes.

Market Growth Drivers:

Several key factors are driving the global Polycaprolactone Market. The rising demand for biodegradable plastics, spurred by environmental regulations and consumer awareness, significantly boosts the market. Polycaprolactone's versatility in blending with other polymers enhances its application in the packaging and medical industries. Additionally, the growing biomedical applications, particularly in tissue engineering, drug delivery, and sutures, further fuel market expansion. The material's ease of processing and compatibility with various manufacturing techniques make it a preferred choice for creating custom-designed biomedical devices, which supports the market's steady growth.

Market Restraints:

Despite promising growth prospects, the Polycaprolactone Market faces challenges related to the high costs associated with PCL production and the availability of cheaper alternatives. The production process for polycaprolactone can be more expensive compared to conventional polymers, which can limit its adoption in cost-sensitive markets. Furthermore, the presence of alternative biodegradable materials, such as polylactic acid (PLA) and polyhydroxyalkanoates (PHA), may pose competition, as they are often available at lower costs. Additionally, the market's growth may be hindered by the limited awareness of PCL's benefits in some regions, necessitating greater educational and marketing efforts to promote its advantages.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of polycaprolactone in high-value applications, such as drug delivery systems and 3D printing. The growing demand for personalized medicine and patient-specific implants creates opportunities for PCL-based products, which offer customizable properties tailored to individual needs. The development of novel PCL composites and blends, designed to enhance mechanical properties and biodegradability, is expected to cater to the growing demand in the biomedical and packaging industries. Moreover, the expansion of the circular economy and sustainability initiatives provides a fertile ground for the broader adoption of polycaprolactone as an eco-friendly alternative to traditional plastics.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Polycaprolactone Market globally?
  • Which types and applications of polycaprolactone are leading the adoption in various industries?
  • How are technological advancements influencing the competitive landscape of the Polycaprolactone Market?
  • Who are the key players in the Polycaprolactone Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Polycaprolactone Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Polycaprolactone Market, including BASF SE, Corbion N.V., and Perstorp Holding AB, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced PCL products and explore new applications in high-growth markets. Collaborations with academic institutions, research organizations, and industry stakeholders facilitate market access and promote new product adoption. Emphasis on sustainability, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Polycaprolactone Market landscape.

Key Companies Profiled:

  • Perstorp Holding A. B.
  • BASF SE
  • Diacel Corporation
  • Sigma-Aldrich Corporation (Merck)
  • Durect Corporation
  • Corbion Purac
  • Shenzen Esun Industrial Co. Ltd.
  • Haihang Industries Co., Ltd.
  • Polysciences, Inc.
  • Shenzhen Polymtek Biomaterial Co. Ltd.

Polycaprolactone Market Industry Segmentation:

Form

  • Pellets
  • Nanosphere
  • Microsphere

Production Method

  • Ring Opening Polymerization
  • Polycondesation of Carboxylic Acid

Application

  • Thermoplastic Polyurethane
  • Healthcare
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South East Asia & Pacific
  • MEA
  • Japan
  • China

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Market Viewpoint

  • 3.1. Parent Market Outlook
  • 3.2. Value Chain Analysis
  • 3.3. Life Cycle Analysis
  • 3.4. Energy Requirement for Polycaprolactone
  • 3.5. Key Regulation
  • 3.6. Macro-economic Factors
  • 3.7. Forecast Factors: Relevance and Impact

4. Market Dynamics

  • 4.1. Market Driver
  • 4.2. Market Restraints
  • 4.3. Market Trend
  • 4.4. Market opportunity

5. Impact of Covid-19 on Market

  • 5.1. Covid-19 The Situation Now
  • 5.2. Effects of National Lockdowns in Various Countries
  • 5.3. Scenarios for Economic Impact of Covid-19 Crisis
  • 5.4. Industries Affected by Coronavirus Outbreak Worldwide
  • 5.5. Projected Recovery for Hardest Hit Sectors
  • 5.6. Coronavirus Impact on The World of Work
  • 5.7. Impact of Covid-19 on Manufacturing Industry
  • 5.8. Manufacturing Purchasing Managers Index, 2024
  • 5.9. Impact of Covid-19 on Supply Chain Worldwide
  • 5.10. Planning & Managing During Covid-19 Pandemic
  • 5.11. Upcoming Pointers Business Leaders Should Focus On

6. Impact of Covid-19 on Polycaprolactone Market

  • 6.1. Covid-19 Impact v/s Value of Polycaprolactone Market, by Country 2020
  • 6.2. Polycaprolactone Sales Projection, 2020 During Covid-19 Pandemic
  • 6.3. Pre Covid-19 Market Forecasts v/s Post Covid-19 Market Forecasts

7. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 7.1. Introduction
    • 7.1.1. Market Value Projections
    • 7.1.2. Market Volume (MT) Projections
    • 7.1.3. Market Size and Y-o-Y Growth
    • 7.1.4. Absolute $ Opportunity
  • 7.2. Global Pricing Analysis
  • 7.3. Intensity Mapping

8. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Form

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Form, 2019-2023
  • 8.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Form, 2024-2032)
    • 8.3.1. Pellets
    • 8.3.2. Nano sphere
    • 8.3.3. Microsphere
  • 8.4. Market Attractiveness Analysis By Form

9. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Production Method

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Production Method, 2019-2023
  • 9.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Production Method, 2024-2032)
    • 9.3.1. Ring Opening polymerization
    • 9.3.2. Polycondesation of carboxylic acid
  • 9.4. Market Attractiveness Analysis By Production Method

10. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Application, 2019-2023
  • 10.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Application, 2024-2032)
    • 10.3.1. Thermoplastic polyurethane
    • 10.3.2. Healthcare
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis By Platform

11. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 11.1. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Region, 2019-2023
  • 11.2. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Region, 2024-2032
    • 11.2.1. North America
    • 11.2.2. Latin America
    • 11.2.3. Europe
    • 11.2.4. South East Asia & Pacific (SEAP)
    • 11.2.5. Middle East & Africa (MEA)
    • 11.2.6. Japan
    • 11.2.7. China
  • 11.3. Market Attractiveness Analysis By Region

12. North America Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 12.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Form
    • 12.3.3. By Production method
    • 12.3.4. By Application
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Form
    • 12.4.3. By Production method
    • 12.4.4. By Application

13. Latin America Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 13.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Rest of Latin America
    • 13.3.2. By Form
    • 13.3.3. By Production method
    • 13.3.4. By Application
  • 13.4. Drivers and Restraints: Impact Analysis
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Form
    • 13.5.3. By Production method
    • 13.5.4. By Application

14. Europe Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 14.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. U.K.
      • 14.3.1.4. Italy
      • 14.3.1.5. Russia
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Nordic countries
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Form
    • 14.3.3. By Production method
    • 14.3.4. By Application
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Form
    • 14.4.3. By Production method
    • 14.4.4. By Application

15. South East Asia & Pacific (SEAP) Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 15.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 15.3.1. By Country
      • 15.3.1.1. ASEAN
      • 15.3.1.2. India
      • 15.3.1.3. Korea
      • 15.3.1.4. ANZ
      • 15.3.1.5. Rest of SEAP
    • 15.3.2. By Form
    • 15.3.3. By Production method
    • 15.3.4. By Application
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Form
    • 15.4.3. By Production method
    • 15.4.4. By Application

16. China Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 16.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 16.3.1. By Form
    • 16.3.2. By Production method
    • 16.3.3. By Application
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Form
    • 16.4.2. By Production method
    • 16.4.3. By Application

17. Japan Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 17.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 17.3.1. By Form
    • 17.3.2. By Production method
    • 17.3.3. By Application
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Form
    • 17.4.2. By Production method
    • 17.4.3. By Application

18. Middle East & Africa (MEA) Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 18.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 18.3.1. By Country
      • 18.3.1.1. GCC
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East & Africa
    • 18.3.2. By Form
    • 18.3.3. By Production method
    • 18.3.4. By Application
  • 18.4. Drivers and Restraints: Impact Analysis
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Form
    • 18.5.3. By Production method
    • 18.5.4. By Application

19. Competition Landscape (Manufactures)

  • 19.1. Market Share Analysis
  • 19.2. Competitive Landscape
  • 19.3. Market Volume share analysis
  • 19.4. Competition Dashboard
  • 19.5. Company Profiles
    • 19.5.1. Perstorp Holding A. B.
      • 19.5.1.1. Overview
      • 19.5.1.2. Product Portfolio
      • 19.5.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.1.4. Production Footprint
      • 19.5.1.5. Sales Footprint
      • 19.5.1.6. Channel Footprint
      • 19.5.1.7. Strategy Overview
        • 19.5.1.7.1. Marketing Strategy
        • 19.5.1.7.2. Product Strategy
        • 19.5.1.7.3. Channel Strategy
    • 19.5.2. BASF SE
      • 19.5.2.1. Overview
      • 19.5.2.2. Product Portfolio
      • 19.5.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.2.4. Production Footprint
      • 19.5.2.5. Sales Footprint
      • 19.5.2.6. Channel Footprint
      • 19.5.2.7. Strategy Overview
        • 19.5.2.7.1. Marketing Strategy
        • 19.5.2.7.2. Product Strategy
        • 19.5.2.7.3. Channel Strategy
    • 19.5.3. Diacel Corporation
      • 19.5.3.1. Overview
      • 19.5.3.2. Product Portfolio
      • 19.5.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.3.4. Production Footprint
      • 19.5.3.5. Sales Footprint
      • 19.5.3.6. Channel Footprint
      • 19.5.3.7. Strategy Overview
        • 19.5.3.7.1. Marketing Strategy
        • 19.5.3.7.2. Product Strategy
        • 19.5.3.7.3. Channel Strategy
    • 19.5.4. Sigma-Aldrich Corporation (Merck)
      • 19.5.4.1. Overview
      • 19.5.4.2. Product Portfolio
      • 19.5.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.4.4. Production Footprint
      • 19.5.4.5. Sales Footprint
      • 19.5.4.6. Channel Footprint
      • 19.5.4.7. Strategy Overview
        • 19.5.4.7.1. Marketing Strategy
        • 19.5.4.7.2. Product Strategy
        • 19.5.4.7.3. Channel Strategy
    • 19.5.5. Durect Corporation
      • 19.5.5.1. Overview
      • 19.5.5.2. Product Portfolio
      • 19.5.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.5.4. Production Footprint
      • 19.5.5.5. Sales Footprint
      • 19.5.5.6. Channel Footprint
      • 19.5.5.7. Strategy Overview
        • 19.5.5.7.1. Marketing Strategy
        • 19.5.5.7.2. Product Strategy
        • 19.5.5.7.3. Channel Strategy
    • 19.5.6. Corbion Purac
      • 19.5.6.1. Overview
      • 19.5.6.2. Product Portfolio
      • 19.5.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.6.4. Production Footprint
      • 19.5.6.5. Sales Footprint
      • 19.5.6.6. Channel Footprint
      • 19.5.6.7. Strategy Overview
        • 19.5.6.7.1. Marketing Strategy
        • 19.5.6.7.2. Product Strategy
        • 19.5.6.7.3. Channel Strategy
    • 19.5.7. Shenzen Esun Industrial Co. Ltd.
      • 19.5.7.1. Overview
      • 19.5.7.2. Product Portfolio
      • 19.5.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.7.4. Production Footprint
      • 19.5.7.5. Sales Footprint
      • 19.5.7.6. Channel Footprint
      • 19.5.7.7. Strategy Overview
        • 19.5.7.7.1. Marketing Strategy
        • 19.5.7.7.2. Product Strategy
        • 19.5.7.7.3. Channel Strategy
    • 19.5.8. Haihang Industries Co., Ltd.
      • 19.5.8.1. Overview
      • 19.5.8.2. Product Portfolio
      • 19.5.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.8.4. Production Footprint
      • 19.5.8.5. Sales Footprint
      • 19.5.8.6. Channel Footprint
      • 19.5.8.7. Strategy Overview
        • 19.5.8.7.1. Marketing Strategy
        • 19.5.8.7.2. Product Strategy
        • 19.5.8.7.3. Channel Strategy
    • 19.5.9. Polysciences, Inc.
      • 19.5.9.1. Overview
      • 19.5.9.2. Product Portfolio
      • 19.5.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.9.4. Production Footprint
      • 19.5.9.5. Sales Footprint
      • 19.5.9.6. Channel Footprint
      • 19.5.9.7. Strategy Overview
        • 19.5.9.7.1. Marketing Strategy
        • 19.5.9.7.2. Product Strategy
        • 19.5.9.7.3. Channel Strategy
    • 19.5.10. Shenzhen Polymtek Biomaterial Co. Ltd.
      • 19.5.10.1. Overview
      • 19.5.10.2. Product Portfolio
      • 19.5.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.10.4. Production Footprint
      • 19.5.10.5. Sales Footprint
      • 19.5.10.6. Channel Footprint
      • 19.5.10.7. Strategy Overview
        • 19.5.10.7.1. Marketing Strategy
        • 19.5.10.7.2. Product Strategy
        • 19.5.10.7.3. Channel Strategy

20. Research Methodology

21. Assumption & Acronyms Used